poisar

Stocks · News reference

Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration

Fiscal.ai

Senseonics and Beta Bionics have officially launched the commercial integration of the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaPadala Satish Kumar Rao

    Senseonics Stock Rises Tuesday on Strong Q3 Revenue, Raised 2026 Outlook

    Shares of Senseonics Holdings Inc (NASDAQ:SENS) are trading higher on Tuesday after the company reported better-than-expected third-quarter financial results and raised its fiscal 2026 revenue guidance above estimates. Raymond James also upgraded the stock to Market Perform from Underperform.